Should Flex prioritize expanding its automotive electronics manufacturing capacity to meet growing demand, or invest in developing new medical device capabilities for long-term diversification?

Introduction

The trade-off we're examining today is whether Flex should prioritize expanding its automotive electronics manufacturing capacity to meet growing demand or invest in developing new medical device capabilities for long-term diversification. This scenario presents a classic dilemma between short-term growth and long-term strategic positioning. I'll analyze this trade-off by considering market dynamics, financial implications, and strategic alignment.

Step 1

Clarifying Questions (3 minutes)

• Based on the current market trends, I'm thinking automotive electronics demand might be cyclical. Could you provide insights into the projected growth rate for automotive electronics over the next 3-5 years?

Why it matters: Helps assess the sustainability of demand and potential return on investment. Expected answer: Steady growth of 5-7% annually. Impact on approach: Higher growth would favor expansion; lower growth might suggest diversification.

• Considering our strategic priorities, I'm assuming medical devices are a new market for us. What's our current market share and expertise in the medical device industry?

Why it matters: Determines the level of investment and risk in entering a new market. Expected answer: Limited presence, less than 1% market share. Impact on approach: Low presence might require significant investment but offer high growth potential.

• Looking at our user impact, I'm thinking about our key automotive clients. How would delayed capacity expansion affect our relationships with major automotive manufacturers?

Why it matters: Assesses potential revenue and relationship risks of not expanding. Expected answer: Risk of losing market share to competitors. Impact on approach: High risk would prioritize expansion; low risk allows for diversification.

• Regarding technical feasibility, I'm curious about our current manufacturing capabilities. How much of our existing infrastructure can be repurposed for medical device production?

Why it matters: Influences the cost and timeline of entering the medical device market. Expected answer: 30-40% of current facilities could be adapted. Impact on approach: Higher adaptability favors diversification; lower adaptability might prioritize automotive expansion.

• Considering resource allocation, what's our current R&D budget as a percentage of revenue, and how would it be affected by either decision?

Why it matters: Determines our capacity to invest in new technologies and markets. Expected answer: 5-7% of revenue, potential to increase to 8-10%. Impact on approach: Higher R&D capacity supports diversification; lower capacity might favor focusing on current strengths.